GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $65,306,000 | +15.9% | 2,044,000 | +25.7% | 1.18% | +29.4% |
| Q1 2022 | $56,345,000 | +379.1% | 1,626,600 | +425.6% | 0.91% | +543.7% |
| Q3 2018 | $11,761,000 | -41.8% | 309,500 | -30.8% | 0.14% | -41.1% |
| Q2 2018 | $20,217,000 | -71.5% | 447,275 | -69.5% | 0.24% | -72.6% |
| Q1 2018 | $70,833,000 | -16.6% | 1,466,530 | -32.0% | 0.88% | -18.2% |
| Q4 2017 | $84,907,000 | +14.2% | 2,157,730 | -9.9% | 1.07% | +51.3% |
| Q3 2017 | $74,322,000 | +25.1% | 2,393,635 | +10.2% | 0.71% | +14.0% |
| Q2 2017 | $59,402,000 | +48.6% | 2,171,935 | +100.3% | 0.62% | +37.5% |
| Q1 2017 | $39,964,000 | – | 1,084,500 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |